Cux2 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the Cux2 protein, also known as Cut-like homeobox 2. Cux2 is a member of the homeobox gene family, which encodes transcription factors involved in regulating gene expression during development and cellular differentiation. Cux2 plays a significant role in the regulation of various developmental processes, including neural development, by influencing the expression of genes that control cell proliferation, migration, and differentiation. As a transcription factor, Cux2 binds to specific DNA sequences in the promoter regions of target genes, modulating their transcriptional activity and thereby contributing to the precise orchestration of gene expression patterns necessary for proper developmental outcomes.
Inhibitors of Cux2 are typically small molecules or peptides designed to interfere with the DNA-binding activity of the Cux2 protein or disrupt its interaction with other transcriptional regulators. By binding to the active sites or allosteric sites of Cux2, these inhibitors prevent the protein from effectively binding to DNA, thereby altering the expression of its target genes. The design and development of Cux2 inhibitors involve detailed knowledge of the protein's structure, particularly its DNA-binding domains and the specific sequences it targets. These inhibitors serve as important tools in the study of Cux2's role in gene regulation, allowing researchers to dissect the molecular mechanisms by which Cux2 influences developmental processes and cellular differentiation. The ongoing research into Cux2 inhibitors provides valuable insights into the complex network of gene regulatory pathways controlled by homeobox transcription factors and underscores the critical role of precise gene expression in development and cellular function. By modulating the activity of Cux2, these inhibitors help elucidate the broader implications of homeobox genes in developmental biology and gene regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D, a transcription inhibitor, directly targets Cux2. By intercalating into DNA, it hinders transcriptional processes involving Cux2, leading to a downregulation of its expression. This inhibition impacts cellular pathways related to gene regulation and DNA binding, influencing cellular functions governed by Cux2 in various tissues. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide is a diterpene triepoxide that indirectly inhibits Cux2. By targeting transcription factors and co-regulators, it disrupts the expression and function of Cux2. This indirect inhibition modulates cellular processes associated with Cux2 in different tissues, affecting DNA binding and gene regulation. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Flavopiridol, a cyclin-dependent kinase inhibitor, directly inhibits Cux2. By disrupting kinase activity, it influences the phosphorylation events critical for Cux2 function. This direct inhibition impacts cellular pathways involving cell cycle regulation and DNA binding, leading to alterations in cellular functions controlled by Cux2 in various tissues. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, indirectly targets Cux2. By demethylating DNA, it induces changes in the epigenetic landscape, affecting Cux2 expression and function. This indirect inhibition modulates cellular processes associated with Cux2 in different tissues, influencing gene regulation and DNA binding. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin, a topoisomerase I inhibitor, directly impacts Cux2. By preventing topoisomerase I activity, it induces DNA damage and inhibits transcription processes involving Cux2. This direct inhibition influences cellular pathways related to gene regulation and DNA binding, leading to alterations in cellular functions governed by Cux2 in various tissues. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, indirectly inhibits Cux2. By modulating histone acetylation, it affects the chromatin structure and Cux2 expression. This indirect inhibition influences cellular processes associated with Cux2 in different tissues, impacting gene regulation and DNA binding. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a polyphenol, indirectly inhibits Cux2. By modulating sirtuin activity and other cellular pathways, it affects Cux2 expression and function. This indirect inhibition influences cellular processes associated with Cux2 in different tissues, impacting gene regulation and DNA binding. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
(+/-)-JQ1, a bromodomain and extraterminal (BET) protein inhibitor, indirectly targets Cux2. By disrupting the interaction between BET proteins and chromatin, it affects the expression and function of Cux2. This indirect inhibition modulates cellular processes associated with Cux2 in different tissues, influencing gene regulation and DNA binding. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine, a DNA methyltransferase inhibitor, indirectly targets Cux2. By demethylating DNA, it induces changes in the epigenetic landscape, affecting Cux2 expression and function. This indirect inhibition modulates cellular processes associated with Cux2 in different tissues, influencing gene regulation and DNA binding. | ||||||